Low VLDL causes: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 57: Line 57:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Hematologic'''
| '''Hematologic'''
|bgcolor="Beige"| [[Acute myeloid leukemia]]
|bgcolor="Beige"|  
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 85: Line 85:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Oncologic'''
| '''Oncologic'''
|bgcolor="Beige"| [[Acute myeloid leukemia]], [[malignancy]]
|bgcolor="Beige"| [[Malignancy]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 109: Line 109:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Rheumatology/Immunology/Allergy'''
| '''Rheumatology/Immunology/Allergy'''
|bgcolor="Beige"| [[Acute phase proteins]], [[amyloidosis]], [[autoimmune diseases]], [[celiac disease]], [[Cytokine|inflammatory cytokines]], [[serum amyloid A]], [[Sjögren's syndrome]]
|bgcolor="Beige"| [[Amyloidosis]], [[autoimmune diseases]], [[celiac disease]], [[Sjögren's syndrome]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 133: Line 133:
{{col-break|width=33%}}
{{col-break|width=33%}}
*[[Abetalipoproteinemia]]
*[[Abetalipoproteinemia]]
*[[Acute myeloid leukemia]]
*[[Acute phase proteins]]
*[[Amyloidosis]]
*[[Amyloidosis]]
*[[Apolipoprotein B deficiency]]
*[[Apolipoprotein B deficiency]]
Line 145: Line 143:
*[[Cirrhosis]]
*[[Cirrhosis]]
*[[Clofibrate]]
*[[Clofibrate]]
*[[Colesevelam (patient information)|Colesevelam hydrochlorie]]
*[[Colestyramine]]
*[[Colestyramine]]
*[[Crohn's disease]]
*[[Crohn's disease]]
Line 160: Line 157:
*[[Hyperlipoproteinemia|Hyperlipoproteinemia, familial type 5]]
*[[Hyperlipoproteinemia|Hyperlipoproteinemia, familial type 5]]
*[[Hypobetalipoproteinemia]]
*[[Hypobetalipoproteinemia]]
*[[Cytokine|Inflammatory cytokines]]
*[[Lymphangiectasia|Intestinal lymphangiectasia]]
*[[Lymphangiectasia|Intestinal lymphangiectasia]]
*[[Ketogenic diet]]
*[[Ketogenic diet]]
Line 177: Line 173:
*[[Probucol]]
*[[Probucol]]
*[[Protein losing enteropathy]]
*[[Protein losing enteropathy]]
*[[Serum amyloid A]]
*[[Short bowel syndrome]]
*[[Short bowel syndrome]]
*[[Shwachman-Diamond syndrome]]
*[[Shwachman-Diamond syndrome]]

Revision as of 17:52, 8 November 2013

Very Low Density Lipoprotein Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Biochemistry

Physiology

Clinical Correlation

High VLDL

Definition
Epidemiology and Demographics
Pathophysiology
Causes
Prognosis and Complications

Low VLDL

Definition
Epidemiology and Demographics
Pathophysiology
Causes
Prognosis and Complications

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Landmark Trials

Future or Investigational Therapies

Case Studies

Case #1

Low VLDL causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Low VLDL causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Low VLDL causes

CDC on Low VLDL causes

Low VLDL causes in the news

Blogs on Low VLDL causes

Directions to Hospitals Treating Very low density lipoprotein

Risk calculators and risk factors for Low VLDL causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]

Overview

Inherited disorders of lipoprotein metabolism like Abetalipoproteinemia and lipid lowering medications and diet are usually associated with low VLDL levels.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Causes by Organ System

Cardiovascular No underlying causes
Chemical/Poisoning No underlying causes
Dental No underlying causes
Dermatologic Dyskeratosis congenita, lipomatosis of Madelung
Drug Side Effect Cilostazol, clofibrate, colestyramine, doxazosin, nicotinic acid, prazosin, probucol, statins
Ear Nose Throat No underlying causes
Endocrine No underlying causes
Environmental Ketogenic diet, malnutrition
Gastroenterologic Celiac disease, chronic liver disease, chronic pancreatitis, cirrhosis, Crohn's disease, exocrine pancreatic insufficiency, intestinal lymphangiectasia, liver failure, portosystemic shunts, protein losing enteropathy, short bowel syndrome
Genetic Abetalipoproteinemia, apolipoprotein B deficiency, Bassen-Kornzweig disease, cystic fibrosis, deficiency of proprotein convertase subtilisin-like/kexin type 9, familial alphalipoprotein deficiency, familial hypobetalipoproteinemia, hyperlipoproteinemia, familial type 5, hypobetalipoproteinemia, lipoprotein lipase deficiency, mutations of the MTTP gene, Shwachman-Diamond syndrome
Hematologic
Iatrogenic Portosystemic shunts, short bowel syndrome
Infectious Disease Giardiasis, Hepatitis C
Musculoskeletal/Orthopedic No underlying causes
Neurologic No underlying causes
Nutritional/Metabolic Abetalipoproteinemia, apolipoprotein B deficiency, Bassen-Kornzweig disease, familial alphalipoprotein deficiency, familial hypobetalipoproteinemia, hyperlipoproteinemia, familial type 5, hypobetalipoproteinemia, lipoprotein lipase deficiency, mutations of the MTTP gene, omega-3 polyunsaturated fatty acids, fish oil
Obstetric/Gynecologic No underlying causes
Oncologic Malignancy
Ophthalmologic No underlying causes
Overdose/Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary No underlying causes
Renal/Electrolyte No underlying causes
Rheumatology/Immunology/Allergy Amyloidosis, autoimmune diseases, celiac disease, Sjögren's syndrome
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous No underlying causes

Causes in Alphabetical Order

References

  1. Scanu, AM.; Aggerbeck, LP.; Kruski, AW.; Lim, CT.; Kayden, HJ. (1974). "A study of the abnormal lipoproteins in abetalipoproteinemia". J Clin Invest. 53 (2): 440–53. doi:10.1172/JCI107578. PMID 11344558. Unknown parameter |month= ignored (help)
  2. Welty, FK.; Mittleman, MA.; Wilson, PW.; Sutherland, PA.; Matheney, TH.; Lipinska, I.; Muller, JE.; Levy, D.; Tofler, GH. (1997). "Hypobetalipoproteinemia is associated with low levels of hemostatic risk factors in the Framingham offspring population". Circulation. 95 (4): 825–30. PMID 9054738. Unknown parameter |month= ignored (help)
  3. Kim HJ, Moon JH, Kim HM, Yun MR, Jeon BH, Lee B; et al. (2013). "The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression". Metabolism. doi:10.1016/j.metabol.2013.09.006. PMID 24139096.
  4. Rojas A, Del Campo JA, Maraver M, Aparcero R, García-Valdecasas M, Diago M; et al. (2013). "Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro". J Viral Hepat. doi:10.1111/jvh.12209. PMID 24188401.


Template:WikiDoc Sources